A study to evaluate the efficacy and safety of TAS-102 in patients with refractory metastatic colorectal cancer
Latest Information Update: 24 Jul 2020
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 24 Jul 2020 New trial record
- 04 Jul 2020 Results presented at the 22nd World Congress on Gastrointestinal Cancer